114 related articles for article (PubMed ID: 16830653)
1. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine.
Matono T; Suzuki S; Mori S; Ato M
Am J Trop Med Hyg; 2024 Mar; 110(3):483-486. PubMed ID: 38266303
[TBL] [Abstract][Full Text] [Related]
3. Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study.
Kumar A; Girdhar A; Girdhar BK
Indian J Med Res; 2013 Oct; 138(4):536-40. PubMed ID: 24434261
[TBL] [Abstract][Full Text] [Related]
4. Ocular complications in newly diagnosed borderline lepromatous and lepromatous leprosy patients: baseline profile of the Indian cohort.
Daniel E; Koshy S; Rao GS; Rao PS
Br J Ophthalmol; 2002 Dec; 86(12):1336-40. PubMed ID: 12446359
[TBL] [Abstract][Full Text] [Related]
5. Leprosy.
Smith WC; Saunderson P
BMJ Clin Evid; 2010 Jun; 2010():. PubMed ID: 21418690
[TBL] [Abstract][Full Text] [Related]
6. Childhood borderline lepromatous leprosy: a case report.
Hutahaean GD; Susanto M; Napitupulu T; Pangihutan-Siahaan AM; Wirjomartani BA
Turk J Pediatr; 2023; 65(5):862-867. PubMed ID: 37853977
[TBL] [Abstract][Full Text] [Related]
7. Erythroderma as a manifestation of leprosy.
Baldissera RL; Shwetz GA; Fillus Neto J; Vigo NDR
An Bras Dermatol; 2019; 94(1):89-92. PubMed ID: 30726471
[TBL] [Abstract][Full Text] [Related]
8. Case for diagnosis. Erythematous and infiltrated plaques in the infrahyoid region.
Bezerra NTC; Schettini APM; Leturiondo AL; Mathias LHMT
An Bras Dermatol; 2021; 96(1):97-99. PubMed ID: 33288364
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunological evaluation after BCG-id vaccine in leprosy patients in a 5-year follow-up study.
Zenha EM; Wambier CG; Novelino AL; de Andrade TA; Ferreira MA; Frade MA; Foss NT
J Inflamm Res; 2012; 5():125-35. PubMed ID: 23293531
[TBL] [Abstract][Full Text] [Related]
10. Leprosy among children under 15 years of age: literature review.
Oliveira MB; Diniz LM
An Bras Dermatol; 2016 Apr; 91(2):196-203. PubMed ID: 27192519
[TBL] [Abstract][Full Text] [Related]
11. Palatal perforation in a patient with borderline lepromatous leprosy: leprosy still not eradicated.
Anand P; Bharadwaj S; Ganguly S; Rao S
BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36192029
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis.
Faujdar J; Gupta P; Natrajan M; Das R; Chauhan DS; Katoch VM; Gupta UD
Indian J Med Res; 2011 Nov; 134(5):696-703. PubMed ID: 22199110
[TBL] [Abstract][Full Text] [Related]
13. Clinical profile of leprosy patients: a prospective study.
Thakkar S; Patel SV
Indian J Dermatol; 2014 Mar; 59(2):158-62. PubMed ID: 24700934
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Type 2 Leprosy Reaction Mimicking Sweet Syndrome: A Case Report and Literature Review.
Bao C; Xu Q; Zou Y; Xiao Z; Cheng B; Gong T; Ji C
Am J Trop Med Hyg; 2024 Mar; 110(3):487-490. PubMed ID: 38350151
[TBL] [Abstract][Full Text] [Related]
15. Type 2 Leprosy Reaction Mimicking Leukocytoclastic Vasculitis in a Postpartum Patient.
Schaffenburg W; Royer M; Scorza M
Am J Dermatopathol; 2023 Dec; 45(12):843-846. PubMed ID: 37883932
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic approach for repurposing immunomodulatory drugs for lepromatous leprosy.
Espitia GJ; Arenas NE; Gutiérrez-Castañeda LD; Guerrero MI
Int J Mycobacteriol; 2023; 12(4):388-393. PubMed ID: 38149532
[TBL] [Abstract][Full Text] [Related]
17. CHANGING TRENDS OF LEPROSY IN ARMED FORCES.
Arora PN; Grover S
Med J Armed Forces India; 1994 Oct; 50(4):259-260. PubMed ID: 28769214
[TBL] [Abstract][Full Text] [Related]
18.
Dogra S; Jain S; Sharma A; Chhabra S; Narang T
Indian Dermatol Online J; 2023; 14(6):753-761. PubMed ID: 38099011
[No Abstract] [Full Text] [Related]
19. A case of lepromatous leprosy in a background of chronic hepatitis B infection.
Jayashankar CA; Prakash B; Prashanthi SVSR; Bhat N; Joshi A; Narayanaswamy G
J Family Med Prim Care; 2024 Apr; 13(4):1559-1562. PubMed ID: 38827665
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Effect of Minocycline as Additional Treatment to Prednisone for Pustular Erythema Nodosum Leprosum.
Gunawan H; Faldian Y; Hindritiani R
Int Med Case Rep J; 2022; 15():263-268. PubMed ID: 35669124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
